Rituximab treatment in patients with primary Sjögren's syndrome: An open-label phase II study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rituximab treatment in patients with primary Sjögren's syndrome: An open-label phase II study

Published:2005 Issue:9 Volume:52 Page:2740-2750
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Pijpe J.,van Imhoff G. W.,Spijkervet F. K. L.,Roodenburg J. L. N.,Wolbink G. J.,Mansour K.,Vissink A.,Kallenberg C. G. M.,Bootsma H.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference42 articles.

1. Malignant lymphoma in primary Sj�gren's syndrome: A multicenter, retrospective, clinical study by the European concerted action on Sj�gren's syndrome

2. Current concepts on diagnosis, autoantibodies and therapy in Sj gren's syndrome

3. Treatment of oral dryness related complaints (xerostomia) in Sjogren's syndrome

4. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

5. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type

Cited by 433 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary Sjögren’s syndrome: new perspectives on salivary gland epithelial cells;European Journal of Medical Research;2024-07-17

2. Update on the pathophysiology and treatment of primary Sjögren syndrome;Nature Reviews Rheumatology;2024-07-09

3. Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus;Autoimmunity Reviews;2024-07

4. Treatment of non-systemic Sjögren's syndrome: Potential prevention of systematization with immunosuppressant agent/biotherapy;Journal of Translational Autoimmunity;2024-06

5. British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease;Rheumatology;2024-04-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3